Drug Profile
Influenza A virus vaccine H5N1 - Fluart Innovative Vaccines
Alternative Names: Fluval H5N1; Fluval P H5N1; Monovalent influenza A H5N1 vaccine - Fluart Innovative VaccinesLatest Information Update: 06 Aug 2021
Price :
$50
*
At a glance
- Originator Omninvest
- Developer Fluart Innovative Vaccines
- Class Influenza A virus H5N1 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Influenza A virus H5N1 subtype
Most Recent Events
- 08 Sep 2008 Launched for Influenza-A virus H5N1 subtype (prevention) in Hungary (IM)
- 27 Sep 2007 National Institute of Pharmacy issues final marketing authorisation for Influenza A virus vaccine H5N1 in Hungary (first global approval)
- 14 Mar 2006 Registered for in Influenza A virus infections H5N1 in Hungary (IM) (temporary approval granted)